Boston's life sciences market is going through a transformational period as tenants re-evaluate what space they actually need. The region's once-hot leasing market slowed dramatically in the second quarter, totaling less than one-third of the activity in the first quarter, according to Cushman & Wakefield data. The firm found that new life sciences demand in Greater Boston totaled 305K SF during Q2.
Cushman & Wakefield Vice Chair Connor Barnes said he thinks the market is stabilizing after unusually high demand earlier in the pandemic.“I don’t think anyone anticipates it going back to that,” Barnes said. “We do anticipate that the demand will begin to normalize sooner than later.”Across the board, 14.7% of the… Read the full story here. |